Short Interest in AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) Declines By 52.7%

AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) saw a large decline in short interest in the month of August. As of August 14th, there was short interest totaling 458,107 shares, a decline of 52.7% from the July 30th total of 968,046 shares. Based on an average trading volume of 631,353 shares, the days-to-cover ratio is presently 0.7 days. Approximately 1.8% of the shares of the company are short sold.

Institutional Investors Weigh In On AGF U.S. Market Neutral Anti-Beta Fund

Large investors have recently bought and sold shares of the company. Crescent Grove Advisors LLC acquired a new stake in shares of AGF U.S. Market Neutral Anti-Beta Fund during the 1st quarter worth approximately $6,614,000. Advisory Services Network LLC lifted its stake in shares of AGF U.S. Market Neutral Anti-Beta Fund by 2,091.7% in the 4th quarter. Advisory Services Network LLC now owns 329,604 shares of the company’s stock valued at $4,743,000 after purchasing an additional 314,565 shares during the period. PMV Capital Advisers LLC lifted its stake in shares of AGF U.S. Market Neutral Anti-Beta Fund by 14.0% in the 1st quarter. PMV Capital Advisers LLC now owns 246,621 shares of the company’s stock valued at $3,443,000 after purchasing an additional 30,234 shares during the period. Bank of New York Mellon Corp boosted its holdings in AGF U.S. Market Neutral Anti-Beta Fund by 59.4% during the first quarter. Bank of New York Mellon Corp now owns 27,235 shares of the company’s stock worth $380,000 after buying an additional 10,146 shares in the last quarter. Finally, Worth Asset Management LLC boosted its holdings in AGF U.S. Market Neutral Anti-Beta Fund by 20.5% during the first quarter. Worth Asset Management LLC now owns 30,472 shares of the company’s stock worth $425,000 after buying an additional 5,190 shares in the last quarter.

AGF U.S. Market Neutral Anti-Beta Fund Price Performance

AGF U.S. Market Neutral Anti-Beta Fund stock traded up $0.22 during trading hours on Friday, hitting $12.25. 471,391 shares of the stock traded hands, compared to its average volume of 800,842. The firm’s 50 day moving average price is $11.84 and its 200-day moving average price is $12.58. The stock has a market capitalization of $308.70 million, a price-to-earnings ratio of 17.67 and a beta of -0.64. AGF U.S. Market Neutral Anti-Beta Fund has a 1 year low of $10.86 and a 1 year high of $16.59.

About AGF U.S. Market Neutral Anti-Beta Fund

The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.